Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.
The Food and Drug Administration granted breakthrough therapy designation to a treatment regimen of two investigational drugs for patients with chronic hepatitis C virus who did not respond to ...
SAN FRANCISCO — An 8-week regimen of the combination of glecaprevir plus pibrentasvir (Mavyret, AbbVie) can eliminate most genotypes of the hepatitis C virus in treatment-naïve patients with ...
Patients with liver disease and hepatitis C, which often occur in congruence, have some good news from UT Southwestern Medical Center researchers. A study found that antiviral drugs for hepatitis C do ...
† One patient had MMF as an initial treatment. ‡ In the study TAC and MMF were used alone or in combination. §In total, 17 patients were initially treated with MMF and steroids. ¶ Females represented ...
Ten years ago, safe and effective treatments for hepatitis C became available. These pills are easy-to-take oral antivirals with few side effects. They cure 95% of patients who take them. The ...
(Reuters Health) - The presence of hepatitis C in potential organ donors has long prevented hearts and lungs from going to patients who desperately need them, but that prohibition may soon disappear ...
Recent research by Diana L. Sylvestre, MD, assistant clinical professor in the Department of Medicine at the University of California, San Francisco, and colleagues suggests that the use of cannabis ...